deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02025751

Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis

Phase 3 Companion Study of Intranasal Metoclopramide in Men With Symptomatic Diabetic Gastroparesis

Sponsor: Evoke Pharma

Updated 10 times since 2017 Last updated: Jun 16, 2020 Started: Apr 30, 2014 Primary completion: Aug 31, 2016 Completion: Oct 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Diabetic Gastroparesis, this trial is completed. The trial is conducted by Evoke Pharma and has accumulated 10 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jul 2017 · 5 months · monthly snapshotCompleted~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotCompleted~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotCompleted~Jul 2018 – ~Aug 2020 · 25 months · monthly snapshotCompleted~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE3

  5. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE3

Show 5 earlier versions
  1. Jul 2018 — Aug 2020 [monthly]

    Completed PHASE3

  2. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE3

  3. Jul 2017 — Jun 2018 [monthly]

    Completed PHASE3

  4. Feb 2017 — Jul 2017 [monthly]

    Completed PHASE3

    Status: Active Not RecruitingCompleted

  5. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Evoke Pharma
Data source: Evoke Pharma

For direct contact, visit the study record on ClinicalTrials.gov .